dabigatran etexilate / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dabigatran etexilate / Generic mfg.
2014-000388-41: Does oral administration of dabigatran etexilate, a direct thrombin inhibitor, achieve significant levels and thrombin inhibiting activity in the eye?

Ongoing
2
24
Europe
Pradaxa(r), Pradaxa(r)
The Rotterdam Eye Hospital, Stichting Wetenschappelijk Onderzoek Oogziekenhuis - Prof. Dr. Flieringa (SWOO)
Ocular accessibility of dabigatran in patients with retinal detachment
 
 
NCT05006287: The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

Active, not recruiting
2
100
Canada
Non-vitamin K oral anticoagulants (NOACs), Apixaban, Dabigatran, Edoxaban, Rivaroxaban, Warfarin
St. Paul's Hospital, Canada
Atrial Fibrillation
05/24
05/24
DOAC/VKA, NCT04002011: DOAC Versus VKA After Cardiac Surgery

Withdrawn
2
206
NA
Warfarin, Coumadin, Dabigatran, Pradaxa, Rivaroxaban, Xarelto, Apixaban, Eliquis, Edoxaban, Lixiana
Laval University
Anticoagulant-induced Bleeding
01/23
03/23

Download Options